美国生物技术公司莫德纳（Moderna）股价今日盘中大跌5.01%，引发市场关注。此次股价下跌主要源于公司宣布的重大裁员计划。
莫德纳首席执行官Stephane Bancel在一份内部备忘录中表示，公司计划在今年年底前裁减约10%的全球员工，以应对新冠疫苗销售下滑带来的财务压力。这一裁员计划将使公司员工人数降至5000人以下。此举是莫德纳此前制定的到2027年削减约15亿美元运营开支计划的一部分。
除了裁员，莫德纳还面临其他挑战。公司第二款主打产品——呼吸道合胞病毒（RSV）疫苗未能获得市场的广泛关注，导致公司大幅下调了今年的营收预期。此外，美国卫生部门政策变化也给公司带来了不确定性。尽管如此，Bancel仍对公司前景保持乐观，称莫德纳现有三款获批产品，未来三年内还有望再推出多达八种新产品。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.